“showed a trend”

CT) showed a trend toward significance ( p = 0.0544), indicating a potential difference in the pain severity for individuals with the CT genotype compared to those with CC or TT genotypes ( Figure 3 C).

Cohort t -test evaluation showed that RT increased mean ADC significantly in three models (U87 p = 0.0121; HCT116 p = 0.0002; CT26 p = 0.0006) but only showed a trend with Calu6 ( p = 0.0545) and 4T1 ( p = 0.1003).

A multivariate regression analysis with MAO-B area fraction as outcome variable, Aβ+ area fraction, number of pTau+ neurofibrillary tangles, GFAP+ reactive astrocytes, and CD68+ reactive microglia, and cortical thickness as independent variables, and adjusted by age at death, confirmed that MAO-B expression level is independently associated with cortical thickness and number of CD68+ reactive microglia and showed a trend ( p = 0.0546) toward a positive independent association with the number of GFAP+ reactive astrocytes, but no significant association with either total Aβ plaque burden or the number of neurofibrillary tangles (Table 6 ).

In the multivariate analysis, concurrent RT emerged as the only independent factor (adjusted HR = 0.180, 95% CI: 0.051-0.632; P = .0075), while prior locoregional therapy showed a trend toward longer OS (adjusted HR = 0.351 95% CI: 0.121-1.021; P = .0546; Table 3 ).

Out of the remaining four miRNAs, three miRNAs, miR-423-3p, miR-320a, and miR-99a-5p were significantly differentially expressed between treatment-naive PCa patients and CRPC ( p = 7.3 × 10 −8 , 0.002 and 0.0186, respectively) ( Figure 2A ), while miR-193a-5p showed a trend without a statistically significant difference ( p = 0.0547).

After mice were exposed to SPS, the level of serum CORT showed a trend toward decrease in the Npffr2 -shRNA-treated group compared to controls ( p = 0.0547, unpaired Student’s t -test) ( Figure 6 B).

As for OW/MS+ individuals, red meat showed a trend toward a positive relationship (β = 16.16, p = 0.0548), and a negative association was observed with eggs (β = −310.14, p = 0.0272).

Although individual PD-L1 ligand expression status did not significantly influence disease-free survival (DFS) in GBM (data not shown), GBM patients with high PD-L2 expression showed a trend of shorter DFS than patients with low expression (Fig. 5A , left)(log rank test P = 0.0548).

However, in the multi-mutant LRRK2 6xD, kinase activity showed a trend to decrease ( p = 0.0549) ( Figure 4 A).

In accordance with previous studies, 5 – 7 CEBPA -dm patients, compared to CEBPA -wt patients, showed a trend toward a higher complete remission rate after the first cycle of treatment (87.5% versus 61.0%, respectively; P =0.0549), longer overall survival (median not reached versus 22.3 months, respectively; P =0.00626; Figure 1A ) and longer disease-free survival (median not reached versus 26.8 months, respectively; P =0.0667; Figure 1B ).

Secondary outcome measure Amongst patients who received information compared to those who did not, those who received information showed a trend in reporting the study experience as being better than expected rather worse or same as expected (p = 0.055).

At 12-months follow-up, participants showed a trend significant improvement exercise capacity (6MWT: 17.9 meters, p = 0.055) compared to UC.

The diagnosis, number of quadrants of MIT/GATT, or the severity of the damage did not influence the need for medications after either surgery, while the number of superficial venular staining in >2 quadrants showed a trend toward significant association with the need for additional medicines (p = -0.1, p = 0.055).

Seasonal Variation and Subtype Interactions Univariate ANOVA showed a trend toward a main effect of molecular subtype on vitamin D levels (F(3,81) = 2.64, p = 0.055), adjusted for season.

For leisure behaviors, although we observed no robust causal impact on OSA, computer use showed a trend for increasing OSA risk after outlier removal (OR = 1.34, p = 0.055).

Those characteristics found to be significant ( p < 0.006 after Bonferroni correction for multiple tests representing an alpha level of 0.05) or showed a trend ( p < 0.055) on univariate analyses were subsequently analyzed in a multivariate manner with the Cox proportional hazards model.

The average daily caloric intake also showed a trend to be higher (P = 0.055) in Vgat-Cre; Clk2 loxP/loxP males (13.61 ± 0.602 kcal/d, n = 6) than in control males (12.17 ± 0.394 kcal/d, n = 9).

Patients in whom the maximum long axis diameter of LNs was more than 10 mm had a 5-year survival rate of 84 % and showed a trend toward better outcomes than those in whom the maximum long axis diameter of LNs was less than 10 mm (74 %; p = 0.055) (Table 5 ).

This effect showed a trend towards being better explained by the cubic function, with z = − 1.922, and p = 0.055, whereas the quadratic function did not yield a comparable decrease in error, z = 0.035, p = 0.972.

Mean RTs and CE rates did not vary significantly depending whether ATD was administered on day 1 or on day 2 but showed a trend for faster RTs on day 2 ( F (1,22) =4.1; p =0.055).

Accordingly, in our analyses, intratumoural CD68 + TAMs did not associate with stage ( P =0.629) or recurrence rate ( P =0.619), whereas peritumoural CD68 + TAMs showed a trend towards lower cell densities in advancing stage ( P =0.055) and in the presence of recurrences ( P =0.080).

EUS-GE also showed a trend toward shorter time to chemotherapy resumption (17 days vs 24 days, p=0.055) and a higher probability of 6-month stent-free survival (95.5% vs 67.7%, log-rank test, p=0.047).

Perineural invasion also showed a trend towards association with overall survival with borderline significance ( P =0.055).

RAB7A expression showed a trend towards increased expression after the addition of RA following RV infection ( P = 0.055) ( Fig. 4 I).

However, cyclists scored higher on sleep‐related behaviors, including sports‐related factors ( p = 0.035, d = 0.54), habitual sleep efficiency ( p = 0.012, d = 0.76), and showed a trend toward better sleep quality ( p = 0.055, d = 0.51) and greater total sleep behavior scores (ASBQ‐Total, p = 0.004, d = 0.82). 3.3.